Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

INBXINBX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in INHIBRX BIOSCIENCES INC

GOLDMAN SACHS GROUP INC holds 338,176 shares of INBX (INHIBRX BIOSCIENCES INC), worth $32M as of 2026-Q2. The position was increased (+255.7% shares). INBX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$32M

Current Shares

338,176

Total Value Change

+$31.2M

Total Shares Change

+280,729

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
338,176
+255.7%
$32M0.0%$94.75
47
2026-Q1
Decreased
95,074
-5.5%
$6.4M0.0%$74.33
0
2025-Q4
Increased
100,617
+287.5%
$7.9M0.0%$77.98
44
2025-Q3
Increased
25,966
+134.2%
$874,5350.0%$32.31
40
2025-Q2
Decreased
11,089
-35.4%
$158,2400.0%$14.43
0
2025-Q1
Decreased
17,165
-70.1%
$240,1380.0%$14.12
0
2024-Q4
New
57,447
-
$884,6830.0%$15.14
34

Other major holders of INBX: MORGAN STANLEY, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used